Xenetic Biosciences, Inc. (XBIO)
2.44
+0.02
(+0.83%)
USD |
NASDAQ |
Dec 12, 16:00
2.43
-0.01
(-0.41%)
Pre-Market: 20:00
Xenetic Biosciences EPS Diluted (Quarterly): -0.3307 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Travere Therapeutics, Inc. | 0.2505 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
| BeyondSpring, Inc. | -0.0382 |
| Solid Biosciences, Inc. | -0.4848 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5099M |
| Revenue (Quarterly) | 1.027M |
| Total Expenses (Quarterly) | 1.537M |
| Enterprise Value | 1.470M |
| Profit Margin (Quarterly) | -49.65% |
| Earnings Yield | -83.88% |
| Normalized Earnings Yield | -70.78 |